1 Department of Medicine, Division of General Medicine, Geriatrics, and Palliative Care, University of Virginia , Charlottesville, Virginia.
2 Department of Medicine, Eastern Maine Medical Center , Veazie, Maine.
J Palliat Med. 2015 Sep;18(9):752-7. doi: 10.1089/jpm.2015.0098. Epub 2015 Jun 5.
Opioids are the mainstay of treatment of cancer pain. With increased use there have been concerns about rising rates of prescription drug abuse and diversion. Although there has been an increase in research and practice guidelines about the scope of the problem for chronic, nonmalignant pain, less information is available about both the frequency of the problem and current practices regarding screening for substance abuse and diversion in patients and family members seen in palliative care clinics.
The aim of this study was to evaluate the degree to which palliative programs felt that substance abuse and diversion was an issue, and to identify practices regarding care of patients with potential substance misuse issues.
We sent a survey regarding substance abuse perception, policies, training, and screening to 94 accredited palliative medicine fellowship program directors as obtained by the Accreditation Council for Graduate Medical Education (ACGME) directory.
We received usable responses from 38 (40.4%) programs. Policies for screening patients (40.5%) or family members (16.2%), dealing with diversion (27%), and use of a screening tool (32.4%) were reported infrequently. Despite this, one-half of respondents indicated that substance abuse and diversion was an issue for their clinics, with only 25% indicating substance abuse was not an issue. Additionally, the majority of fellows (83%) and about half (47%) of staff received mandatory training for dealing with substance misuse. All programs provided some screening of patients, with 48.7% screening all patients for abuse. Screening of family members was relatively rare, as was routine use of the urine drug screen (UDS).
Despite increased concerns about substance abuse, the majority of programs did not have substance abuse and diversion policies or report screening all patients, with screening of caregivers rarely reported. Consensus guidelines addressing substance abuse and diversion for palliative patients are needed to address this growing problem.
阿片类药物是治疗癌痛的主要药物。随着阿片类药物使用的增加,人们对处方药物滥用和转用的上升率感到担忧。尽管关于慢性非恶性疼痛问题的范围已经有了更多的研究和实践指南,但关于在姑息治疗诊所中患者和家属中物质滥用和转用问题的频率和当前实践的信息较少。
本研究旨在评估姑息治疗项目对物质滥用和转用问题的重视程度,并确定处理有潜在物质滥用问题的患者的护理实践。
我们向通过研究生医学教育认证委员会(ACGME)目录获得的 94 个姑息医学奖学金项目主任发送了一份关于物质滥用认知、政策、培训和筛查的调查。
我们收到了 38 个(40.4%)项目的有效回复。报告的患者(40.5%)或家属(16.2%)筛查政策、处理转用(27%)和使用筛查工具(32.4%)的情况很少。尽管如此,一半的受访者表示他们的诊所存在物质滥用和转用问题,只有 25%的受访者表示物质滥用不是问题。此外,大多数研究员(83%)和大约一半(47%)的工作人员接受了处理物质滥用的强制性培训。所有项目都对患者进行了一些筛查,48.7%的患者筛查了所有患者的滥用情况。对家属的筛查相对较少,常规使用尿液药物筛查(UDS)也较少。
尽管对物质滥用的担忧增加,但大多数项目没有物质滥用和转用政策,或报告对所有患者进行筛查,很少报告对照顾者进行筛查。需要制定姑息治疗患者物质滥用和转用问题的共识指南来解决这一日益严重的问题。